Seattle Cancer Care Alliance (SCCA) was formed, in part, to bring promising new treatments to patients faster. This means patients may find more treatment options at SCCA than they find elsewhere, including the chance to participate in one of many ongoing clinical studies conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine.

Not all patients are cured with standard therapy, and some standard treatments may have more side effects than are desired. So patients may seek help through clinical studies. Patients who participate in these studies, also called clinical trials, have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about their disease and its treatment.

Clinical trials come in four phases. In Phase I trials, investigators try to determine the most effective and safe dosage. In Phase II trials, which involve a larger group of patients, researchers hope to build on what they learned in the first phase by trying to establish response rates and response durations, and by trying to determine what side effects will occur. In Phase III trials, researchers compare the experimental treatment with the standard treatment. In Phase IV trials, researchers monitor the effects of long-term usage.

  • For general information about clinical trials, click here.
  • For more information about clinical studies available at SCCA, see the Patient Guide to Clinical Studies.
  • You can also search by type of disease for radiation oncology-specific clinical studies at SCCA that are currently open and accepting patients.